P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

• Katja Weisel,
• Anita D’souza,
• David Hurd,
• Peter Voorhees,
• Raphael Teipel,
• Alfred Chung,
• Cesar Rodriguez,
• Sacha Tuchman,
• Neha Korde,
• Hana Safah,
• Orlando Bueno,
• Zhongling Feng,
• Tanya Rosenberg,
• Rajvineeth Kumar Pothacamury,
• Jeremy Ross,
• Shane Lee,
• Ziyi Jin,
• Chetasi Talati,
• Shaji Kumar,
• Ravi Vij

Affiliations

Katja Weisel

1 University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, Hamburg, Germany

Anita D’souza

2 Froedtert & Medical College of Wisconsin Cancer Center, Division of Hematology/Oncology, Department of Medicine, Milwaukee, United States

David Hurd

3 Wake Forest University School of Medicine, Section of Hematology and Oncology, Department of Medicine, Winston-Salem, United States

Peter Voorhees

4 Levine Cancer Institute, Atrium Health/Wake Forest Baptist, Plasma Cell Disorders Division, Department of Hematologic Oncology & Blood Disorders, Charlotte, United States

Raphael Teipel

5 Universitätsklinikum Dresden, Medizinische Klinik I, Dresden, Germany

Alfred Chung

6 University of California San Francisco, Division of Hematology/Oncology, Department of Medicine, San Francisco, United States

Cesar Rodriguez

7 Mount Sinai, Division of Hematology/Oncology, Department of Internal Medicine, New York, United States

Sacha Tuchman

8 University of North Carolina at Chapel Hill, Division of Hematology, Chapel Hill, United States

Neha Korde

9 Memorial Sloan Kettering Cancer Center, Myeloma Service, Department of Medicine, New York, United States

Hana Safah

10 Tulane University School of Medicine, Tulane Cancer Center, New Orleans, United States

Orlando Bueno

11 AbbVie Inc., North Chicago, United States

Zhongling Feng

11 AbbVie Inc., North Chicago, United States

Tanya Rosenberg

11 AbbVie Inc., North Chicago, United States

Rajvineeth Kumar Pothacamury

11 AbbVie Inc., North Chicago, United States

Jeremy Ross

11 AbbVie Inc., North Chicago, United States

Shane Lee

11 AbbVie Inc., North Chicago, United States

Ziyi Jin

11 AbbVie Inc., North Chicago, United States

Chetasi Talati

11 AbbVie Inc., North Chicago, United States

Shaji Kumar

12 Mayo Clinic Rochester, Division of Hematology, Rochester, United States

Ravi Vij

13 Washington University School of Medicine, St. Louis, United States